Anna Popova, Aiga Vasiļvolfa, Kārlis Rācenis, Renārs Erts, Baiba Šlisere, Anna Jana Saulīte, Ieva Ziedina, Inese Folkmane, Harijs Čerņevskis, Juta Kroiča, Aivars Pētersons, Viktorija Kuzema
BACKGROUND Kidney transplantation is the treatment of choice for most patients with end-stage renal disease. To improve patient and transplant survival, non-invasive diagnostic methods for different pathologies are important. Leucine-rich alpha-2-glycoprotein (LRG-1) is an innovative biomarker that is elevated in cases of angiogenesis, inflammation, and kidney injury. However, there are limited data about the diagnostic role of LRG-1 in kidney transplant recipients. The aim of this study was to evaluate the association between serum LRG-1, urine LRG-1, and kidney transplant function and injury...
September 6, 2022: Annals of Transplantation: Quarterly of the Polish Transplantation Society